US2002165136A1PendingUtilityA1
MHC peptides and methods of use
Est. expiryAug 28, 2016(expired)· nominal 20-yr term from priority
A61K 38/00C07K 14/70539
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
MHC or HLA Class I peptides and compositions thereof are provided for the specific induction of apoptosis of cancer cells in a patient. Methods of treating cancer cells in patients suffering from cancer employing the MHC or HLA Class I peptides of the invention. Also provided are methods of identifying MHC or HLA Class I peptides and variants thereof capable of killing cancerous cells in vivo in a patient suffering from cancer.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of killing a cancer cell in a patient, comprising administering to said patient an amount of an MHC or HLA Class I peptide sufficient to kill said cancer cell.
2 . The method of claim 1 , wherein said peptide is selected by use of an in vivo or in vitro apoptosis screening assay.
3 . The method of claim 2 , wherein said assay is an in vivo diffusion chamber assay.
4 . The method of claim 2 , wherein the cells used for said assay are cancer cells obtained from said patient.
5 . The method of claims 1 , 2 , 3 , or 4 , wherein said MHC or HLA Class I peptide is selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, SEQ ID NO: 7, SEQ ID NO: 8, SEQ ID NO: 9, SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12 and SEQ ID NO: 13.
6 . A composition comprising an MHC or HLA Class I peptide for use in the method of claims 1 , 2 , 3 or 4 .
7 . Use of the composition of claim 6 for the induction of apoptosis in a cancer cell in vivo.
8 . A method of arresting the growth of a cancerous tumor in a patient, comprising administering to said patient an amount of an MHC or HLA Class I peptide sufficient to arrest the growth of said tumor.
9 . The method of claim 8 , wherein said tumor exhibits regression.
10 . The method of claim 8 , wherein said tumor is killed.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.